| Page 27 | Cafepharma

You are here

Primary tabs

Krystal Biotech Ramps Up to Manufacture Gene Therapy to Treat Dystrophic Epidermolysis Bullosa

Post date: January 15, 2019 - 9:51am

FDA Accepts Pfizer Submissions for Review of Treatment for Rare Amyloid Related Heart Disease

Post date: January 14, 2019 - 10:09am

Release: Vascular Therapies Appoints John McDermott as Chief Executive Officer

Post date: January 10, 2019 - 3:22pm

Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders

Post date: January 7, 2019 - 10:05am

Atlantic Therapeutics Raises $32 Million in Series B Financing After FDA Approves is Device to Treat Incontinence

Post date: January 7, 2019 - 9:48am

Ribon Therapeutics Raises $65 Million to Advance Novel Cancer Pipeline

Post date: January 4, 2019 - 9:13am

Ablative Solutions Banks $77 Million in Series D Funding for Unique Approach to Treating Uncontrolled Hypertension

Post date: January 3, 2019 - 9:50am

Suvodirsen For Duchenne Muscular Dystrophy Selected for FDA Complex Innovative Trial Designs Pilot Program

Post date: January 3, 2019 - 9:41am

Orphan Drug Designation Granted to Investigational Gene Therapy for Rare Form of Muscular Dystrophy

Post date: January 2, 2019 - 9:54am

Biotech Venture Firm Closes $250 Million Opportunity Fund

Post date: January 2, 2019 - 9:46am

Pages